[Early diagnosis, therapy, and research in the control of leprosy].
D000814:Aniline Compounds / Q000627:therapeutic use; D004357:Drug Synergism; D005060:Europe; D006801:Humans; D006931:Hyperbaric Oxygenation; D007538:Isoniazid / Q000627:therapeutic use; D007918:Leprosy / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy; D010619:Phenazines / Q000627:therapeutic use; D013450:Sulfones / Q000009:adverse effects / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use; D013997:Time Factors; D014329:Tropical Climate; D014481:United States; D014805:Vitamin B 12 / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use
D000814:Aniline Compounds; D010619:Phenazines; D013450:Sulfones; D014803:Vitamin B Complex; D013792:Thalidomide; D014805:Vitamin B 12; D007538:Isoniazid
Die Frühdiagnose, Therapie und Forschung in der Leprabekämpfung.